questionText: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of making Proleukin available for motor neurone disease patients on the NHS.
answerText: We have made no assessment. It is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products R...
heading: Motor Neurone Disease: Aldesleukin